MedTrace Logo

Adherence, Improvement Measure (AIM) System

NCT01252212 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2013-11-20

No results posted yet for this study

Summary

In this project, we will work directly with underserved patients in a safety-net setting to conduct a randomized clinical trial of standard-of-care adherence counseling versus a novel adherence intervention embedded in an existing PHR that uses cellular phone short message service (SMS) reminders and patient responses to the reminders. We will compare adherence rates in both arms as assessed by antiretroviral medication concentrations in hair samples and self-report; clinical outcomes will also be compared in the two arms. The project will examine medication adherence for antiretroviral medications and treatments of common conditions such as depression, hypertension, diabetes and hypercholesterolemia.

Conditions

  • Patient Compliance
  • AIDS

Interventions

BEHAVIORAL

SMS medication adherence

SMS messages to cell phones.

BEHAVIORAL

No SMS adherence reminder

In this arm, patients will be sent supportive lifestyle suggestions to their phone using SMS technology but will not be sent a reminder regarding their medication adherence.

Sponsors & Collaborators

  • The Commonwealth Fund

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • James Kahn, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-02-29
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01252212 on ClinicalTrials.gov